| pubmed-article:11331333 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11331333 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11331333 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:11331333 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:11331333 | lifeskim:mentions | umls-concept:C0002210 | lld:lifeskim |
| pubmed-article:11331333 | lifeskim:mentions | umls-concept:C0205851 | lld:lifeskim |
| pubmed-article:11331333 | lifeskim:mentions | umls-concept:C1141639 | lld:lifeskim |
| pubmed-article:11331333 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:11331333 | lifeskim:mentions | umls-concept:C1521828 | lld:lifeskim |
| pubmed-article:11331333 | lifeskim:mentions | umls-concept:C1522609 | lld:lifeskim |
| pubmed-article:11331333 | lifeskim:mentions | umls-concept:C1554112 | lld:lifeskim |
| pubmed-article:11331333 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:11331333 | pubmed:dateCreated | 2001-5-1 | lld:pubmed |
| pubmed-article:11331333 | pubmed:abstractText | The prognostic significance of the rate of decline of the serum tumor marker alpha-fetoprotein (AFP) and human chorionic gonadotrophin (HCG) during the first two cycles of chemotherapy in germ cell tumor (GCT) patients was initially reported by us, but its value has been debated. We re-examined this issue in the context of the International Germ Cell Cancer Collaborative Group (IGCCCG) risk classification system and investigated the role of including in the analysis patients whose markers normalized early. | lld:pubmed |
| pubmed-article:11331333 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11331333 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11331333 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11331333 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11331333 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11331333 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11331333 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11331333 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11331333 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11331333 | pubmed:month | May | lld:pubmed |
| pubmed-article:11331333 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:11331333 | pubmed:author | pubmed-author:HigginsGG | lld:pubmed |
| pubmed-article:11331333 | pubmed:author | pubmed-author:BoslG JGJ | lld:pubmed |
| pubmed-article:11331333 | pubmed:author | pubmed-author:MazumdarMM | lld:pubmed |
| pubmed-article:11331333 | pubmed:author | pubmed-author:BajorinD FDF | lld:pubmed |
| pubmed-article:11331333 | pubmed:author | pubmed-author:MotzerR JRJ | lld:pubmed |
| pubmed-article:11331333 | pubmed:author | pubmed-author:BacikJJ | lld:pubmed |
| pubmed-article:11331333 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11331333 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:11331333 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:11331333 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11331333 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11331333 | pubmed:pagination | 2534-41 | lld:pubmed |
| pubmed-article:11331333 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:11331333 | pubmed:meshHeading | pubmed-meshheading:11331333... | lld:pubmed |
| pubmed-article:11331333 | pubmed:meshHeading | pubmed-meshheading:11331333... | lld:pubmed |
| pubmed-article:11331333 | pubmed:meshHeading | pubmed-meshheading:11331333... | lld:pubmed |
| pubmed-article:11331333 | pubmed:meshHeading | pubmed-meshheading:11331333... | lld:pubmed |
| pubmed-article:11331333 | pubmed:meshHeading | pubmed-meshheading:11331333... | lld:pubmed |
| pubmed-article:11331333 | pubmed:meshHeading | pubmed-meshheading:11331333... | lld:pubmed |
| pubmed-article:11331333 | pubmed:meshHeading | pubmed-meshheading:11331333... | lld:pubmed |
| pubmed-article:11331333 | pubmed:meshHeading | pubmed-meshheading:11331333... | lld:pubmed |
| pubmed-article:11331333 | pubmed:meshHeading | pubmed-meshheading:11331333... | lld:pubmed |
| pubmed-article:11331333 | pubmed:meshHeading | pubmed-meshheading:11331333... | lld:pubmed |
| pubmed-article:11331333 | pubmed:meshHeading | pubmed-meshheading:11331333... | lld:pubmed |
| pubmed-article:11331333 | pubmed:meshHeading | pubmed-meshheading:11331333... | lld:pubmed |
| pubmed-article:11331333 | pubmed:meshHeading | pubmed-meshheading:11331333... | lld:pubmed |
| pubmed-article:11331333 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11331333 | pubmed:articleTitle | Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy. | lld:pubmed |
| pubmed-article:11331333 | pubmed:affiliation | Department of Epidemiology and Biostatistics and the Genitourinary Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. mazumdar@biost.mskcc.org | lld:pubmed |
| pubmed-article:11331333 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11331333 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:11331333 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11331333 | lld:pubmed |
